The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALPHABET INC | CAP STK CL C | 02079K107 | 18,342 | 100 | SH | SOLE | 100 | 0 | 0 | ||
ARDELYX INC | COM | 039697107 | 6,347,902 | 856,667 | SH | SOLE | 856,667 | 0 | 0 | ||
AVADEL PHARMACEUTICALS PLC | COM SHS | G29687103 | 1,159,950 | 82,500 | SH | SOLE | 82,500 | 0 | 0 | ||
BATTALION OIL CORP | COM | 07134L107 | 24,793 | 7,423 | SH | SOLE | 7,423 | 0 | 0 | ||
BLUEBIRD BIO INC | COM | 09609G100 | 667,540 | 678,256 | SH | SOLE | 678,256 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 1,241,170 | 49,000 | SH | SOLE | 49,000 | 0 | 0 | ||
BURGERFI INTERNATIONAL INC | COM | 12122L101 | 557,425 | 2,745,938 | SH | SOLE | 2,745,938 | 0 | 0 | ||
BURGERFI INTERNATIONAL INC | *W EXP 12/16/202 | 12122L119 | 26,251 | 2,083,438 | SH | SOLE | 2,083,438 | 0 | 0 | ||
ENPHYS ACQUISITION CORP | CL A ORD SHS | G3167L109 | 857,813 | 78,125 | SH | SOLE | 78,125 | 0 | 0 | ||
FENNEC PHARMACEUTICALS INC | COM | 31447P100 | 1,038,700 | 170,000 | SH | SOLE | 170,000 | 0 | 0 | ||
GERON CORP | COM | 374163103 | 2,671,200 | 630,000 | SH | SOLE | 630,000 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 4,712,445 | 70,335 | SH | SOLE | 70,335 | 0 | 0 | ||
ISHARES TR | RUSSELL 2000 ETF | 464287655 | 16,738,425 | 82,500 | SH | Put | SOLE | 82,500 | 0 | 0 | |
JASPER THERAPEUTICS INC | COM NEW | 471871202 | 726,400 | 32,000 | SH | SOLE | 32,000 | 0 | 0 | ||
KINIKSA PHARMACEUTICALS INTL | ORD SHS CL A | G52694109 | 1,954,581 | 104,691 | SH | SOLE | 104,691 | 0 | 0 | ||
LUMOS PHARMA INC | COM | 55028X109 | 210,642 | 90,794 | SH | SOLE | 90,794 | 0 | 0 | ||
MARINUS PHARMACEUTICALS INC | COM NEW | 56854Q200 | 2,474,348 | 2,114,827 | SH | SOLE | 2,114,827 | 0 | 0 | ||
MICROSOFT CORP | COM | 594918104 | 44,695 | 100 | SH | SOLE | 100 | 0 | 0 | ||
MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 3,089,073 | 2,340,207 | SH | SOLE | 2,340,207 | 0 | 0 | ||
MINERALYS THERAPEUTICS INC | COM | 603170101 | 924,300 | 79,000 | SH | SOLE | 79,000 | 0 | 0 | ||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 1,538,550 | 45,000 | SH | Put | SOLE | 45,000 | 0 | 0 | |
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 1,149,545 | 8,350 | SH | SOLE | 8,350 | 0 | 0 | ||
REGENXBIO INC | COM | 75901B107 | 424,125 | 36,250 | SH | SOLE | 36,250 | 0 | 0 | ||
SERES THERAPEUTICS INC | COM | 81750R102 | 246,643 | 340,761 | SH | SOLE | 340,761 | 0 | 0 | ||
SPDR SER TR | S&P BIOTECH | 78464A870 | 4,635,500 | 50,000 | SH | Put | SOLE | 50,000 | 0 | 0 | |
SPRUCE BIOSCIENCES INC | COM | 85209E109 | 38,828 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 1,334,450 | 65,000 | SH | SOLE | 65,000 | 0 | 0 |